Treatment

9 % Braun Injektionslösung clinical trials

3 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Multicenter, Randomized, Partially Blinded, Palivizumab-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for Severe RSV Disease
This study is testing a new medicine, Clesrovimab (also called MK-1654), to help protect babies and young children from a serious breathing illness called RSV. Researchers want to see how well it works and if it's safe compared to a current treatment.
For: Prevention of Respiratory syncytial virus (RSV) infection in infants and children at increased risk for severe RSV disease
Germany · Spain · Hungary
Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3 Randomized Double-blind Controlled Study to Evaluate the Immunogenicity, Safety, and Reactogenicity of ExPEC9V and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or Older
This study looks at a new vaccine to prevent serious E. coli infections and a strong flu vaccine in people aged 65 and over. Researchers want to see how well they work, how safe they are, and if they can be given together.
For: Prevention of invasive extraintestinal pathogenic Escherichia coli (ExPEC) disease
Belgium · Poland
Ongoing, recruitingTherapeutic use (Phase IV)
An investigation of clinical outcomes and inflammatory response to heparin free extracorporeal membrane oxygenation support during clinical lung transplantation – a prospective double-blind randomised feasibility study. “Zero-Hep”
This study, called "Zero-Hep," is looking into how well a new way of doing lung transplants works. It's focused on a special type of life support called ECMO, but without using a blood-thinning medicine called heparin. Researchers want to see if this method causes fewer blood clots and other problems.
For: Lung transplantation
Austria

A Phase 3, Multicenter, Randomized, Partially Blinded, Palivizumab-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for Severe RSV Disease

A Phase 3 Randomized Double-blind Controlled Study to Evaluate the Immunogenicity, Safety, and Reactogenicity of ExPEC9V and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or Older

An investigation of clinical outcomes and inflammatory response to heparin free extracorporeal membrane oxygenation support during clinical lung transplantation – a prospective double-blind randomised feasibility study. “Zero-Hep”